Back to search
Multi-resistant Gram-negative Bacteria Cause Infection
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Multi-resistant Gram-negative Bacteria Cause Infection trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Multi-resistant Gram-negative Bacteria Cause Infection trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is an open, open-label, parallel, single-dose, phase I clinical study designed to evaluate the pharmacokinetic (PK) profile of TQD3524 injection in patient…
Background and rationale: Antimicrobial resistance is a global public health threat. An increasing number of Gram-negative bacteria isolates worldwide are resi…